ST6GAL1
Beta-galactoside alpha-2,6-sialyltransferase 1
Also known as: CDw75, SIAT1, SIAT1_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P15907
- Gene
- ST6GAL1
- Ensembl
- ENSG00000073849
- Chromosome
- 3
- Canonical length
- 406 aa
- Protein class
- Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted secreted proteins
- Secretome location
- Secreted to blood
- Quaternary structure
- Homodimer
OverviewNCBI Gene
This gene encodes a member of glycosyltransferase family 29. The encoded protein is a type II membrane protein that catalyzes the transfer of sialic acid from CMP-sialic acid to galactose-containing substrates. The protein, which is normally found in the Golgi but can be proteolytically processed to a soluble form, is involved in the generation of the cell-surface carbohydrate determinants and differentiation antigens HB-6, CD75, and CD76. This gene has been incorrectly referred to as CD75. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2017]
Canonical amino-acid sequenceUniProt
406 residues, UniProt reviewed canonical sequence.
>P15907|ST6GAL1
1 MIHTNLKKKF SCCVLVFLLF AVICVWKEKK KGSYYDSFKL QTKEFQVLKS LGKLAMGSDS
61 QSVSSSSTQD PHRGRQTLGS LRGLAKAKPE ASFQVWNKDS SSKNLIPRLQ KIWKNYLSMN
121 KYKVSYKGPG PGIKFSAEAL RCHLRDHVNV SMVEVTDFPF NTSEWEGYLP KESIRTKAGP
181 WGRCAVVSSA GSLKSSQLGR EIDDHDAVLR FNGAPTANFQ QDVGTKTTIR LMNSQLVTTE
241 KRFLKDSLYN EGILIVWDPS VYHSDIPKWY QNPDYNFFNN YKTYRKLHPN QPFYILKPQM
301 PWELWDILQE ISPEEIQPNP PSSGMLGIII MMTLCDQVDI YEFLPSKRKT DVCYYYQKFF
361 DSACTMGAYH PLLYEKNLVK HLNQGTDEDI YLLGKATLPG FRTIHCLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ST6GAL1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.31
- Highest tissue expression
- 464 nTPM
Expression across tissuesHPA
Tissue
- liver: 464 nTPM
- tonsil: 139 nTPM
- lymph node: 95 nTPM
- spleen: 64 nTPM
- thymus: 62 nTPM
- thyroid gland: 61 nTPM
Single-cell type
- microglia: 2,268 nCPM
- plasma cells: 1,276 nCPM
- b-cells: 990 nCPM
- renal collecting duct principal cells: 795 nCPM
- hepatocytes: 695 nCPM
- salivary duct cells: 573 nCPM
Immune cell
- memory B-cell: 88 nTPM
- naive B-cell: 84 nTPM
- naive CD4 T-cell: 81 nTPM
- total PBMC: 59 nTPM
- naive CD8 T-cell: 59 nTPM
- memory CD4 T-cell: 52 nTPM
Brain region
- medulla oblongata: 109 nTPM
- white matter: 107 nTPM
- spinal cord: 99 nTPM
- pons: 97 nTPM
- thalamus: 88 nTPM
- midbrain: 85 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.57
- gnomAD pLI
- 0.23
- gnomAD missense Z
- 1.15
- DepMap mean gene effect
- 0.1
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- N-acetylneuraminate metabolic process
- protein N-linked glycosylation via asparagine
- protein O-linked glycosylation via N-acetyl-galactosamine
- sialylation
- viral protein processing
Molecular functions
- beta-galactoside alpha-2,6-sialyltransferase activity
- protein homodimerization activity
- sialyltransferase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ST6GAL1 as an antibody target. Whether an autoantibody or antibody against ST6GAL1 could matter depends on whether native ST6GAL1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ST6GAL1 is annotated as secreted, so native ST6GAL1 circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label ST6GAL1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...